Average Co-Inventor Count = 7.55
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mirati Therapeutics, Inc. (14 from 38 patents)
2. Rapt Therapeutics, Inc. (6 from 13 patents)
3. Array Biopharma Inc. (3 from 329 patents)
4. Flx Bio, Inc. (2 from 2 patents)
22 patents:
1. 12421228 - Naphthyridine derivatives as PRC2 inhibitors
2. 12371435 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
3. 12304915 - SOS1 inhibitors
4. 12280055 - Combination therapies
5. 12252493 - Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
6. 12098139 - Chemokine receptor modulators and uses thereof
7. 11964989 - KRas G12D inhibitors
8. 11702418 - SOS1 inhibitors
9. 11492351 - MTA-cooperative PRMT5 inhibitors
10. 11485738 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
11. 11479551 - MTA-cooperative PRMT5 inhibitors
12. 11453683 - KRas G12D inhibitors
13. 11384064 - Chemokine receptor modulators and uses thereof
14. 11220509 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
15. 11192879 - Chemokine receptor modulators and uses thereof